Related Experiment Video
Updated: May 4, 2026
07:26
Assessing Pupil-linked Changes in Locus Coeruleus-mediated Arousal Elicited by Trigeminal Stimulation
Published on: November 26, 2019
8.0K
The Relationship between Removable Dental Prostheses and Brain Activity in Elderly Individuals: Systematic Review
Arpit Sikri1, Jyotsana Sikri2, Rinshul Saroch3
1Department of Prosthodontics, Crown & Bridge, and Oral Implantology, Bhojia Dental College & Hospital, Baddi, Himachal Pradesh, India.
Rambam Maimonides Medical Journal
|January 29, 2025
Summary
Wearing removable dental prostheses is linked to better cognitive function in older adults. This supports their role in preventing cognitive decline and maintaining brain health.
Area of Science:
- Gerontology
- Neuroscience
- Dental Medicine
Background:
- Growing evidence links edentulism (tooth loss) to cognitive impairment.
- Cognitive decline is a significant concern in the elderly population.
- The role of dental interventions in brain health requires further investigation.
Purpose of the Study:
- To systematically review studies on removable dental prostheses and cognitive function.
- To investigate the impact of prostheses on cerebral changes in edentulous patients.
- To explore the potential of dental prostheses in mitigating cognitive deterioration.
Main Methods:
- Systematic review adhering to PRISMA guidelines.
- Searched PubMed, Scopus, and Web of Science databases.
- Included studies published in English up to June 2023; risk of bias assessed.
Main Results:
- 13 studies met inclusion criteria from 86 initially screened.
- A positive association was found between removable dental prosthesis use and cognitive function.
- Findings suggest therapeutic potential for managing cognitive decline.
Conclusions:
- Removable dental prostheses are crucial for neurological health in the elderly.
- Prosthesis use may help prevent cognitive decline.
- Consideration of dental prostheses is important in managing neurodegenerative diseases.
Related Concept Videos
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
01:30Cognitive Development During Adulthood
1.4K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35